These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34580043)

  • 21. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
    Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma.
    Tinmouth A; Zanke B; Imrie KR
    Leuk Lymphoma; 2001 Mar; 41(1-2):137-45. PubMed ID: 11342365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
    Cao TM; Horning S; Negrin RS; Hu WW; Johnston LJ; Taylor TL; Shizuru JA; Hoppe RT; Brown BW; Blume KG; Stockerl-Goldstein KE
    Biol Blood Marrow Transplant; 2001; 7(5):294-301. PubMed ID: 11400952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular lymphoma: a therapeutic update.
    Italiano A; Thyss A
    Bull Cancer; 2005 Oct; 92(10):E57-64. PubMed ID: 16266867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?
    Seyfarth B; Kuse R; Sonnen R; Glass B; Schmitz N; Dreger P
    Ann Hematol; 2001 Jul; 80(7):398-405. PubMed ID: 11529465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months.
    Lunning MA; Migliacci JC; Hilden P; Devlin SM; Castro-Malaspina H; Giralt S; Perales MA; Zelenetz AD; Moskowitz CH; Sauter CS
    Br J Haematol; 2016 Apr; 173(2):260-4. PubMed ID: 26847389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances.
    Epperla N; Hamadani M
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):277-284. PubMed ID: 28633038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
    Boughan KM; Caimi PF
    Curr Oncol Rep; 2019 May; 21(7):63. PubMed ID: 31119485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
    Klyuchnikov E; Bacher U; Kröger NM; Hari PN; Ahn KW; Carreras J; Bachanova V; Bashey A; Cohen JB; D'Souza A; Freytes CO; Gale RP; Ganguly S; Hertzberg MS; Holmberg LA; Kharfan-Dabaja MA; Klein A; Ku GH; Laport GG; Lazarus HM; Miller AM; Mussetti A; Olsson RF; Slavin S; Usmani SZ; Vij R; Wood WA; Maloney DG; Sureda AM; Smith SM; Hamadani M
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2091-2099. PubMed ID: 26253007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
    Federico M; Bellei M; Marcheselli L; Luminari S; Lopez-Guillermo A; Vitolo U; Pro B; Pileri S; Pulsoni A; Soubeyran P; Cortelazzo S; Martinelli G; Martelli M; Rigacci L; Arcaini L; Di Raimondo F; Merli F; Sabattini E; McLaughlin P; Solal-Céligny P
    J Clin Oncol; 2009 Sep; 27(27):4555-62. PubMed ID: 19652063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
    Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current therapeutic strategies and new treatment paradigms for follicular lymphoma.
    Kritharis A; Sharma J; Evens AM
    Cancer Treat Res; 2015; 165():197-226. PubMed ID: 25655611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma.
    Sabloff M; Atkins HL; Bence-Bruckler I; Bredeson C; Fergusson D; Genest P; Hopkins H; Hutton B; Mcdiarmid S; Huebsch LB
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):956-64. PubMed ID: 17640600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Past, present and future of prognostic scores in follicular lymphoma.
    Mozas P; Rivero A; López-Guillermo A
    Blood Rev; 2021 Nov; 50():100865. PubMed ID: 34187710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.
    Alig S; Jurinovic V; Shahrokh Esfahani M; Haebe S; Passerini V; Hellmuth JC; Gaitzsch E; Keay W; Tahiri N; Zoellner A; Rosenwald A; Klapper W; Stein H; Feller A; Ott G; Staiger AM; Horn H; Hansmann ML; Pott C; Unterhalt M; Schmidt C; Dreyling M; Alizadeh AA; Hiddemann W; Hoster E; Weigert O
    Blood Adv; 2020 Sep; 4(18):4451-4462. PubMed ID: 32941649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life.
    Sortais C; Lok A; Tessoulin B; Gastinne T; Mahé B; Dubruille V; Blin N; Touzeau C; Moreau A; Bossard C; Peterlin P; Garnier A; Guillaume T; Le Bourgeois A; Chevallier P; Moreau P; Leux C; Le Gouill S
    Ann Hematol; 2020 Jul; 99(7):1595-1604. PubMed ID: 32417940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualized management of follicular lymphoma.
    Bai B; Huang HQ
    Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
    Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW
    Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world.
    Manna M; Lee-Ying R; Davies G; Stewart C; Oh DH; Peters A; Stewart DA
    Leuk Lymphoma; 2019 Jan; 60(1):133-141. PubMed ID: 29966465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.